Sign in

CIK 0001447028

  • Non-accelerated filer
  • Smaller reporting company

Arbutus Biopharma Corp

Sign in to watch
Ticker
ABUS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
Operating
EIN
980597776
Phone
+1 604-419-3200
Business address
701 VETERANS CIRCLE, WARMINSTER, PA, 18974
Former names
TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 16 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-07-11 Sofia Michael J. Chief Scientific Officer Sale −10,000 $10.00 $100K 1,503,403
2018-07-09 Sofia Michael J. Chief Scientific Officer Sale −10,000 $8.91 $89K 1,513,403
2018-07-06 Sofia Michael J. Chief Scientific Officer Sale −10,000 $8.45 $85K 1,523,403
2018-07-05 Sofia Michael J. Chief Scientific Officer Sale −10,000 $8.40 $84K 1,533,403
2018-07-03 Sofia Michael J. Chief Scientific Officer Sale −10,000 $8.00 $80K 1,543,403
2018-06-19 HENRIQUES RICHARD C JR Director Grant or award · Director Stock Option (Right to Buy) +22,000 22,000
2018-06-19 CONRAD HERBERT J Director Grant or award · Director Stock Option (Right to Buy) +22,000 22,000
2018-06-19 MANCHESTER KEITH S Director Grant or award · Director Stock Option (Right to Buy) +22,000 22,000
2018-06-19 Ramaswamy Vivek Director Grant or award · Director Stock Option (Right to Buy) +22,000 22,000
2018-06-19 BURGESS DANIEL D Director Grant or award · Director Stock Option (Right to Buy) +22,000 22,000
2018-06-19 HASTINGS DAVID C Chief Financial Officer Grant or award · Employee Stock Option (Right to Buy) +200,000 200,000
2018-04-17 Murray Mark J. President & CEO Option exercise +27,007 $0.35 $10K 316,396
2018-04-17 Murray Mark J. President & CEO Option exercise · Employee Stock Option (Right to Buy) −27,007 0
2018-04-16 Sofia Michael J. Chief Scientific Officer Grant or award · Employee Stock Option (Right to Buy) +160,000 160,000
2018-04-16 Murray Mark J. President & CEO Grant or award · Employee Stock Option (Right to Buy) +418,187 418,187
2018-04-16 VandenEnden Koert Interim CFO Grant or award · Employee Stock Option (Right to Buy) +25,000 25,000
2018-04-16 Symonds William T. Chief Development Officer Grant or award · Employee Stock Option (Right to Buy) +30,000 30,000
2018-04-16 Howard Elizabeth Exec. VP & General Counsel Grant or award · Employee Stock Option (Right to Buy) +150,000 150,000
2018-01-12 SVF Investments (UK) Ltd 10% owner Purchase · Series A Participating Convertible Preferred Shares +664,000 $100.00 $66.4M 1,164,000
2018-01-12 Dexxon Holdings Ltd. 10% owner Purchase · Series A Participating Convertible Preferred Shares +664,000 $100.00 $66.4M 1,164,000

Page 9 of 12 · 239 trades